ArticleCancer communications (London, England)2023

MFSD2A potentiates gastric cancer response to anti-PD-1 immunotherapy by reprogramming the tumor microenvironment to activate T cell response.

Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.